Viking Global Investors reported profitability in its hybrid hedge fund and private asset fund for the third quarter, with returns of 1% and 4.2%, respectively. However, these opportunities funds have underperformed compared to Viking's public funds, which saw gains of 9.3% and 18.2% this year. The firm, managing over $48 billion, is increasing its private investments, recently participating in a $115 million Series B for Triveni Bio and acquiring a minority stake in Humaneva for $50 million.
